Dicerna Pharmaceuticals Inc. (DRNA) Gained 5.18% or 0.69 To Price $14.0 On Tuesday


Dicerna Pharmaceuticals Inc. (DRNA) gained 5.18% or 0.69 to $14.0. It is nearly 118368 shares traded, which is 20.65% compare to the average total volume 573337. The market cap of DRNA is $739.50 million. The year to date change is 47.38%. The 52 week price range is from $2.69 to $15.8. Price of DRNA have changed 5.63% during last week. It have changed -5.80% over last month, -6.92% over last 3 months, 38.50% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 13.10. It is -6.43% below current price. The 200-day Moving Averages for DRNA is 10.81. It is -22.79% below current price. The 52-week High is 15.8. It is 12.86% from the current price. The 52-week Low is 2.69. It is -80.79% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DRNA is 5.37 on 2018-07-13. Short % to float is 8.17%. There are some statistics of DRNA. It is has market cap $739.50 million. The share outstanding is 52.82 million. The average volume is 573337. The revenue is 726000. The percent of top 15 Institution holding is 86.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -134.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -108.90%.


Tags:

Share this post